Tumor heterogeneity poses a significant challenge for predicting responses to cancer therapy, highlighting the need for the development of biomarkers to guide personalized treatment. Contrast-enhanced ...
SuperLightNet is an ultra-lightweight multimodal framework for brain tumor segmentation, employing a parameter-efficient architecture with only 2.97 million parameters. Compared to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results